normative
Expanded access must be planned before trials end
Companies should plan supply chains, import licenses, and regulatory pathways for compassionate use before pivotal trials finish, so a promising drug can reach anyone in need quickly.
normativepending
Speaker
JohnEvidence Quote
“we have to be prepared to provide it to anybody in need”
Created: 11/18/2026, 9:59:31 AM
Your notes
Loading notes...